Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Real-world Effectiveness of maTernAl RSVpreF vaccInation Against RSV-associated Acute Respiratory ilLness in Infants in BrAzil (TARSILA Study): a Multicentre, Prospective, Test-negative, Case-Control Study

NCT07445763 is registered in ClinicalTrials.gov with Inova Medical as lead sponsor.

NCT NCT07445763
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07445763 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Real-world Effectiveness of maTernAl RSVpreF vaccInation Against RSV-associated Acute Respiratory ilLness in Infants in BrAzil (TARSILA Study): a Multicentre, Prospective, Test-negative, Case-Control Study
Lead sponsor
Inova Medical
Phase
Observational
Overall status
Not yet recruiting
Start date
April 30, 2026
Completion date
December 31, 2028
Enrollment
5,000 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

acute respiratory illness (ari), infant outcomes, lower respiratory tract disease, maternal immunization, respiratory syncytial virus (rsv)